richard16 2016-05-12 14:18
当心血管疾病(心脏病或中风)确诊后,医生会提供治疗建议,但病人的决定是至关重要的。美国心脏协会(AHA)与 以病人为中心的成果研究所(PCORI)合作,网络征集文章。你可以是患者,社区志愿者,家庭成员或任何人,只要你有这方面的亲身经验。根据你的情况来阐述患者的治疗决策是怎样做出的,例如:对寿命的影响,对生活质量的影响,费用,或其他?同时关心过程的完整性,时间,等等。。。 “请于2016年6月9日之前将稿件上传到:https://www.innocentive.com/ar/workspace/challengeDetail?challenge=9933835“ THE CHALLENGE Treatment of heart disease and stroke often requires patients and their families to make many decisions on how to move forward after a cardiac event. Specifically, AHA and PCORI are interested in learning about the “decisional dilemmas” you face – your insights will help guide future research to improve heart health. Based on the input from you and others in the patient and caregiver community, we will identify important concerns and use the perspectives to target research towards what matters most. Despite multiple available treatment options that your physician may describe, you may not always know which option is right/best for you. Tell us about the most difficult decision that you or your family faced when evaluating treatment options for heart disease or stroke. In addition, we would like to understand more about what you considered most important when making this choice or decision. Please pick your top three choices and tell us why they are important to you and your family: Side effects of the treatment Complexity of treatment plan Difficulty in adhering to a treatment Impact on my quality of life Potential to prolong my life Whether the best option for me is selected based on research of people similar to me (personal characteristics such as my age, race and gender) Whether my family history and genetic makeup would influence the effectiveness of a given option Whether a trusted source recommended a specific option The financial impact of the options for me and my family Other:________ Any submission should address the following Submission Requirements: The submission can be from anyone (patient, caregiver, family member, or other)   [更多]
悬赏:
悬赏
¥0.00
已托管
载入中...
richard16 2016-05-16 17:23
再生药的发展领域,主要集中在修复和取代受损细胞组织或病源组织。干细胞有自我修复功能。胚胎干细胞可以开发成身体内任何形式的细胞组织,成体干细胞的功能是维护或修复身体内部的细胞。Boiheringer Ingelheim的寻找目标是:调动,刺激,分化新的内源性干细胞分子结构的途径。 投标截止时期2016年6月24日, 投标网址:https://www.innocentive.com/ar/challenge/9933855 原文 Mobilization, Stimulation, and Differentiation of Endogenous Stem Cells TAGS: Chemistry, Royal Society of Chemistry, Life Sciences, Ideation AWARD: $15,000 USD | DEADLINE: 6/24/16 | ACTIVE SOLVERS: 51 | POSTED: 4/25/16 1. The Challenge and qualification for the award During early development, embryonic stem cells are undifferentiated cells that can be stimulated to proliferate and develop into all different cell types. In adults, these endogenous cells are found in tissues and they can divide either to replenish the stem cell population or differentiate into specialized cells of the tissue in which they reside. These adult stem cells function as an internal maintenance or repair system, so it would be beneficial to be able to direct and enhance this regenerative capacity. Therefore, Boehringer Ingelheim (the Seeker) desires the identification of new molecular mechanisms and pathways involved in mobilization, stimulation, and differentiation of endogenous stem cells. All submitted solutions will be considered for the award. There will be a guaranteed award for at least one submitted solution. The total payout will be $15,000, with the possibility to distribute it amongst one or more Solvers, with at least one award being no smaller than $5,000 and no award being smaller than $1,000. 2. Additional application for Research Funding In addition to consideration for the award for the submitted solutions, Solvers with appropriate qualifications and expertise having access to a suitable research laboratory and equipment can apply for research funding (“Research Funding”) to execute the research plan that is proposed in the solution. The selection of candidates for Research Funding will be conducted after completion of this Challenge   [更多]
悬赏:
悬赏
¥0.00
载入中...
richard16 2016-05-16 17:27
为健康动物做明显标记的染料或颜料,通常有以下2种限制: 1. 染料往往是活性的,因此不容易褪色,并有强烈的产品活性成分。 2. 颜料活性低,不粘附皮肤,所以容易被清洗。 目标要求是研发一种能在动物体上染色的环保材料(如:染料,颜料或其他) 或者一种配方能够达到相同效果。 投标截止时期2016年5月29日, 投标网址https://www.innocentive.com/ar/challenge/9933850 原文 Challenge Overview The Seeker to this Challenge has a cleaning product for animal hygiene to which the Seeker intends to add the capability to stain skin with a clear, visible mark. Various dyes and pigments exist with the potential to provide this feature, however two limitations have been found: • Dyes tend to be reactive, hence not staining and consuming the active ingredient of the product. • Pigments are less reactive, do not adhere to skin, and are therefore easily washed out. The Challenge is to develop a highly colored version of the cleaning product adding to it the ability to stain animal skin. Hence, the Seeker is looking for ideas for ingredients (dyes, pigments, or others) and/or formulations that can overcome the above identified limitations and achieve this effect. This is a Theoretical Challenge that requires only a written proposal to be submitted. The Challenge award will be contingent upon theoretical evaluation of the proposal by the Seeker. Submissions to this Challenge must be received by 11:59 PM (US Eastern Time) on May 29, 2016. Late submissions may not be considered. To receive an award, the Solvers will have to transfer to the Seeker their exclusive Intellectual Property (IP) rightsto the solution.   [更多]
悬赏:
悬赏
¥0.00
载入中...
佳佳妹 2015-07-09 15:41
现广泛征集药品说明书,每篇1元。具体要求如下: 1.提交的说明书是扫描版或者是图片格式。 2.提交的说明书要内容清晰、完整。说明书内容必须与市场上的药品说明书相符,即真实可信。 3.提交的说明书需要是药智网药品说明书里面还没有收录的。网址:http://db.yaozh.com/index.php?action=instruct 请自行输入药品名称查询(对比生产厂家、核准日期和其他说明书里面的内容)。 4.交稿方式:按以下格式交稿,但是不上传说明书。说明书直接联系我,并将说明书打包发给我,审核之后付款。 5..交稿格式: 个数: 目录:1.药品名称 生产厂家 2. 药品名称 生产厂家 3…… 注意:不接收说明书数据库已有的和已提交合格的说明书。越早提交合格率越高。具体事宜可直接联系我。联系QQ:2102176267   [更多]
悬赏:
悬赏
¥50.00
已托管
载入中...
佳佳妹 2014-09-22 10:46
2元一个求购《新药转正标准》里中药部分的说明书。《新药转正标准》有1-88册,分中药部分与西药部分。目前求购中药部分中的使用说明书,2元一份。我已有54、62、66、68、74、84-88册的使用说明书。现在需要求购余下的说明书,具体要求如下: 1、稿件格式可以为扫描版PDF,内容清晰,完整 2、交稿时请注明是哪一册的哪个药物的说明书 3、请勿投我已经有的说明书   [更多]
悬赏:
悬赏
¥2000.00
已托管
载入中...
jason831 2015-09-11 21:26
五种质子泵抑制剂PPI:奥美拉唑、兰索拉唑、泮托拉唑、雷贝拉唑、埃索美拉唑。国内或进口的说明书扫描或照片,要求图像清晰。   [更多]
悬赏:
悬赏
¥90.00
已托管
载入中...
用户名不能少 2018-11-16 16:01
具体要求: ① 求购云南省中药 饮片标准/药材标准/炮制规范 PDF版(价格为5元/篇): 为云南省食药监局历年通过发文补充的上述标准/规范,文件编号为云YNZYC-XXXX-XXXX-XXXX、云YPBZ-XXXX-XXXXX、云PZGF-XXXX-XXXX等格式的。 ②PDF文件要求:真实、无水印、完整、清晰,来源可靠(非网上百度所得)。 ② 若发现文件有误或不完整,相应扣除一定的赏金。 补充:目前已有云PZGF-0003-2018、云PZGF-0005-2018、云PZGF-0006-2018、云PZGF-0004-2018、云PZGF-0002-2016、云PZGF-0001-2016、云YPBZ-0209-2014、云YPBZ-0205-2014、云YNZYC-0363-2015-2017、云YNZYC-0329-2010-2016   [更多]
悬赏:
悬赏
¥200.00
已托管
载入中...
用户名不能少 2019-01-17 15:32
① 求购云南省中药 饮片标准/药材标准/炮制规范 PDF版(价格为5元/篇): 为云南省食药监局历年通过发文补充的上述标准/规范,文件编号为云YNZYC-XXXX-XXXX-XXXX、云YPBZ-XXXX-XXXXX、云PZGF-XXXX-XXXX等格式的。 ②PDF文件要求:真实、无水印、完整、清晰,来源可靠(非网上百度所得)。 ② 若发现文件有误或不完整,相应扣除一定的赏金。 补充:目前已有云PZGF-0003-2018、云PZGF-0005-2018、云PZGF-0006-2018、云PZGF-0004-2018、云PZGF-0002-2016、云PZGF-0001-2016、云YPBZ-0209-2014、云YPBZ-0205-2014、云YNZYC-0363-2015-2017、云YNZYC-0329-2010-2016、云YPBZ-0214-2015、云PZGF-0007-2018   [更多]
悬赏:
悬赏
¥190.00
已托管
载入中...
佳佳妹 2015-07-23 14:42
说明书征集任务赏金领取处 审核合格者,在下方投稿。每个稿件可以领取10元   [更多]
悬赏:
悬赏
¥100.00
已托管
载入中...
郭诗琦666 02-25 10:59
赏金30元/件。 《内蒙古中药饮片炮制规范》1963版 及 2020年版; 《内蒙古中药材切制规范》1977版; 《宁夏中药饮片炮制规范》2017版。 若提供其他现行标准,请先与任务主联系,否则视为不需要的不合格稿件。   [更多]
悬赏:
悬赏
¥90.00
已托管
载入中...
发布需求,坐等药智客上门
  • 安全可靠,先验收再正式付款
  • 性价比超高,节省一半费用
  • 80%的需求得到了圆满解决
立即发布需求

推荐任务